Pacira BioSciences, Inc. (PCRX) Institutional Ownership

Ownership Summary

According to SEC filings for the period ending September 2025, Pacira BioSciences, Inc. (NASDAQ:PCRX) is held by 237 institutional firms.

• These investors collectively held 106.0% of the company's total shares outstanding in September 2025, down from 115.4% in June 2025.
• Quarterly data indicates a -0.54% shift in institutional share volume, and the annual owner count reflects a decrease of 1.66%.
• During the quarter, 103 institutions bought more Pacira BioSciences shares, 96 sold shares, and 38 of the 237 total investors held their position steady.
• The total number of shares held by institutions in Pacira BioSciences decreased to 47.97Mn as of September 2025, a net change of down by 261.93K shares quarter on quarter, and down 3.57Mn shares year over year.
• As of September 30, 2025, BlackRock, Inc. held Pacira BioSciences's largest shareholding position with over 7.34Mn shares, representing 16.21% of total outstanding shares.
• Among the most significant buyers of Pacira BioSciences during September 2025 were Doma Perpetual Capital Management LLC (897.25K), ADAGE CAPITAL PARTNERS GP, L.L.C. (410.00K), AMERICAN CENTURY COMPANIES INC (196.00K), MORGAN STANLEY (192.73K), ROYAL BANK OF CANADA (169.21K).
• Leading sellers of Pacira BioSciences stock in September 2025 included MILLENNIUM MANAGEMENT LLC (624.57K), BlackRock, Inc. (459.83K), JACOBS LEVY EQUITY MANAGEMENT, INC (332.16K), D. E. Shaw & Co., Inc. (311.22K), RENAISSANCE TECHNOLOGIES LLC (257.40K).
• The top 10 institutional holders of Pacira BioSciences for the quarter ending September 2025 included BlackRock, Inc. (7.34Mn), VANGUARD GROUP INC (5.20Mn), Doma Perpetual Capital Management LLC (2.70Mn), DIMENSIONAL FUND ADVISORS LP (2.16Mn), RENAISSANCE TECHNOLOGIES LLC (2.14Mn), D. E. Shaw & Co., Inc. (1.94Mn), STATE STREET CORP (1.90Mn), BALYASNY ASSET MANAGEMENT L.P. (1.89Mn), AMERICAN CENTURY COMPANIES INC (1.38Mn), GOLDMAN SACHS GROUP INC (1.31Mn).